Integrated Diagnostics Holdings plc ends 2024 on strong note delivering 39% and 115% year-on-year top- and bottom-line growth
(London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan announced today its audited financial statements for the year ended 31 December 2024. IDH reported revenue of EGP 5,720 million, representing a year-on-year increase of 39% supported by both rising test and patient volumes (up 9% and 5% year-on-year, respectively) combined with higher average revenue per test. Further down the income statement, the Company’s efforts to optimize operations and keep a tight grip on costs translated into improved margins at all levels of profitability. More specifically, in FY 2024, IDH reported a net profit of EGP 1,008 million, up 115% year-on-year and with a bottom-line margin of 17.6% versus 11.4% in FY 2023.